Clinical Trials Browser

Phase 2 × INDUSTRY × Verteporfin × Clear all

NCT02939274 2018-07-20

An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer

Phase 2 Unknown

Breast Neoplasms